ABSTRACT PURPOSE: To evaluate the changes in corneal transparency and thickness measured objectively using Pentacam Scheimpfl ug (Oculus Optikgeräte GmbH) corneal tomography (densitometry) after corneal cross-linking (CXL).
RESULTS:
Immediately after CXL, central corneal thickness signifi cantly decreased (Ϫ40 µm) and corneal densitometry increased signifi cantly. At 6-month followup, densitometry values were reduced and seemed to stabilize at a higher value than baseline. No statistically signifi cant differences were noted (mean difference at 12 months: ϩ30%). Changes in corneal densitometry were detected with the Pentacam even when clinical haze did not increase beyond grade 1 during follow-up.
CONCLUSIONS:
Corneal CXL is associated with a transient reduction in central corneal thickness, which recovered to baseline after 12 months. During the same time period, corneal densitometry experienced a transient increase that recovered to baseline values after 3 months. Changes in compactness of the corneal tissue after CXL may have an impact in corneal power not due to curvature changes, but to refractive index changes as a result of hydration changes. Pentacam is a useful objective method to monitor corneal transparency after CXL. resently, corneal collagen cross-linking (CXL) with ribofl avin A is the only pharmacological treatment available for keratoconus. 1 This treatment is intended to reinforce the corneal architecture by cross-linking the stromal lamellae in a transversal way. 2 Several studies have proven that the treatment is safe, effective, and provides the desired stability of the condition 3 as well as improves several topographic indices and visual acuity compared with untreated eyes. 4 Despite this, the mechanism by which the anterior corneal surface changes towards a fl atter shape is not clear. Mechanical stretching of the corneal tissue could be related with the compaction of the collagen lamellae, thus thinning the cornea. 5 However, it could also be argued that the entire cornea would stretch, thus exerting some backward movement that could be observed as a change in the posterior corneal surface and potentially on anterior chamber depth as measured with current Scheimpfl ug optical tomography. 6 Transient corneal haze is a relatively common side effect of CXL and refl ects the healing process of the cornea. [7] [8] [9] [10] Currently, haze can be measured objectively by optical methods such as Scheimpfl ug photography. 11 The goal of this study was to objectively evaluate changes in central corneal thickness (CCT) and transparency after CXL in patients with keratoconus, as measured with Pentacam (Oculus Optikgeräte GmbH, Wetzlar, Germany).
PATIENTS AND METHODS
Twenty-two eyes from 15 patients with keratoconus were evaluated with Pentacam. To minimize the effect of diurnal changes in corneal hydration, all measurements were performed between 2:00 and 6:00 PM. 12 Two days before treatment, patient eyelids were washed every 12 hours and a combination of dexamethasone and chloramphenicol was instilled three times a day.
Topical anesthesia of the cornea was obtained using oxybuprocaine and tetracaine drops, alternating every 3 minutes for 9 minutes. During this time period, pilocarpine 2% eye drops were also instilled twice. After a lid speculum was inserted, a 9.0-mm diameter corneal abrasion was created. Ribofl avin 0.1% drops were instilled every 3 minutes for 30 minutes. The ribofl avin drops were prepared immediately before treatment by mixing aqueous ribofl avin 0.5% solution with dextran T-500 20% solution. Central corneal pachymetry was performed using ultrasound. In eyes with a CCT (without epithelium) Ͻ400 µm, additional ribofl avin 0.1% drops without dextran (hypoosmotic drops) were applied until the thickness was Ͼ400 µm. The eyes were inspected at the slit-lamp to ensure that the ribofl avin had penetrated the aqueous (blue light).
The eye was irradiated for 30 minutes with an ultraviolet-A irradiance of 3 mW/cm 2 (UV-X; Peschke Meditrade GmbH, Hunenberg, Switzerland). During irradiation, the cornea was moistened every 5 minutes with ribofl avin 0.1% drops and oxybuprocaine drops every 10 minutes. Ofl oxacin 0.3% ointment was applied at the end of the procedure and the eye was patched. Patients were informed to use the tobramycin drops every 2 hours for 5 days. After epithelial healing, patients used topical fl uorometholone two times a day for 3 months. For eyes with sterile infi ltrates during the early postoperative period, dexamethasone drops were prescribed fi ve times a day for 1 week, after which the drops were tapered during the following 2 weeks. All procedures were uneventful.
Statistical analysis was conducted with SPSS 18.0 (SPSS Inc, Chicago, Illinois). Signifi cance of changes over time was assessed using analysis of variance after assessing normality in the data distribution with the Shapiro-Wilks W-test. Changes at subsequent followup compared with baseline were assessed using paired sample t tests. PϽ.05 was considered statistically signifi cant. Figure 1 is representative topographies before and 2 months after CXL. Figure 2 shows changes in CCT over 1 year of follow-up after CXL. A statistically signifi cant decrease was noted immediately after treatment (PϽ.01 at 1 month and PϽ.05 at 3 and 6 months), returning to baseline values after 12 months (PϾ.05). Figure 3 illustrates transient changes in corneal transparency showing a signifi cant increase in corneal densitometry after 1 month and remaining stable up to 3 months (PϽ.05 against baseline) with reduction and stabilization of corneal transparency at 6 and 12 months postoperatively. These changes were present despite the absence of signifi cant haze observed on slit-lamp examination (no patient showed values over grade 1 on clinical observation). Table A (available as supplemental material in the PDF version of this article) presents the changes in clinical and morphological corneal parameters showing mild changes in keratoconus indices over the course of follow-up. Index of vertical asymmetry (Fig 4) and index of height asymmetry (Fig 5) at 1 and 3 months (PϽ.05 against baseline) returned to baseline values after 6 months. 
RESULTS

DISCUSSION
Transient haze is a common side effect of corneal CXL. This reaction is related to the healing process after treatment and is commonly graded subjectively by slitlamp examination, which may not detect mild changes between follow-up visits. This is considered a transient consequence of the histological changes induced by the alteration of the cross-linked structure of the stroma, but defi nitive changes have also been documented. 8 Haze formation is a concern after CXL, as it can potentially limit the benefi ts of the treatment by diminishing the transparency of the cornea, thus limiting the potential visual acuity achievable by means of subsequent treatments [13] [14] [15] or contact lens fi tting. 16 This study demonstrates that Pentacam densitometry measures are able to detect statistically signifi cant changes in corneal transparency 1 year after CXL in patients with keratoconus. The signifi cant increase and subsequent decrease in corneal densitometry after CXL in patients with keratoconus agrees with a study from Greenstein et al 11 reporting the reduction of haze graded clinically with the slit-lamp from grade 0.78 to 0.06 1 year after treatment. However, values observed in the present study are markedly higher despite patients not showing clinical haze over grade 1 on slitlamp examination.
It is well known that haze related with CXL is different from haze related with other treatments such as photorefractive keratectomy (PRK). Although PRKinduced haze is limited to the subepithelial area, CXLrelated haze achieves up to 60% of the stromal depth. There have been several speculations regarding the etiology of haze in CXL and several studies have related it to loss of keratocytes. 9 Other potential explanations may relate this occurrence with the histological changes in terms of collagen structure. After CXL, the new molecular bridges established between collagen lamellae may affect the organization of the stromal structure responsible for corneal transparency. This effect is seen by evaluating the changes in corneal thickness immediately after treatment where marked thinning is present. Although haze and thinning are both related with the healing process and collagen reorganization into the corneal stroma, the time period Corneal Transparency After CXL for Keratoconus/Gutiérrez et al of change is markedly different, with corneal transparency recovering faster than corneal thickness.
The transient increase in some keratoconus indices is potentially related with the structural changes taking place within the cornea, which is refl ected in the present study by a transient statistically significant increase in keratoconus grading and an increase in the index of height asymmetry; although this was not statistically signifi cant due to the higher variability in this parameter. The structural changes taking place after CXL may have signifi cant implications in terms of refraction mediated by the potential changes in the refractive index of the cornea.
Unless a loss of collagen lamellae could be demonstrated, which is not likely as this will potentially result in weak corneal tissue after CXL for keratoconus, changes in corneal thickness seem to refl ect a compactness of corneal stroma. We assume that keratocyte 9 and fundamental substance loss will result in a significant loss of hydration and consequently a decrease in refractive index. A recent study has shown that CXL is related to increased keratocyte apoptosis, followed by a process of regeneration that may explain the transient haze noted after CXL. 17 Another explanation of the thickness changes could be a misinterpretation of the anterior and posterior edges of the cornea by Pentacam as a result of the changes in induced transparency. However, in our patients, we ensured that all images were processed correctly and no misdetection of the posterior border occurred, thus we ruled out this potential source of error for this sample. Moreover, other nonoptical techniques have obtained similar or higher thinning results. Holopainen and Krootila, 5 using ultrasound pachymetry, observed an average thinning of 87 µm just after treatment, which recovered to baseline after 6 months. It seems that the reduction in corneal thickness measured with ultrasound pachymetry following CXL may refl ect a true thinning effect of the treatment, thus supporting the Pentacam results.
Corneal thickness changes may be relevant in the understanding of the refractive changes in CXL. Assuming an increase in the compactness of the dry tissue, this will eventually result in an increase in the refractive index of the cornea. Leonard and Meek 18 obtained refractive indices of 1.411 and 1.365 for the fi brils and extrafi brillar material, respectively, in human corneal stroma and found that areas of more compactness, such as the center and anterior stroma, 19 have lower refractive index, likely due to a higher proportion of extrafi brillar material. 20 This effect will be combined with the presence of a thinner corneal tissue. However, a decrease in corneal thickness of 100 µm will have minor impact in the overall power of the cornea (Ͻ0.01 D). Changes in corneal hydration as a consequence of the CXL procedure could have greater refractive implications. Let us consider the known relationship between hydration and refractive index of hydrophilic soft materials (HEMA-based) as an example to apply here. In this case, the refractive index of the cornea could change from 1.376 (assuming 78% corneal hydration or soft hydrogel Vasurfi lcon A with equilibrium water content of 74% and a refractive index of 1.379) to 1.415 (corresponding to Etafi lcon A material with 55% equilibrium water content assuming that a 100-µm reduction in CCT will result in approximately 20% to 25% volume loss). This increase in refractive index will also increase the overall power of the cornea in the myopic direction by approximately 6.00 to 7.00 D for a 6.5-mm corneal curvature in the anterior surface and 5.5-mm curvature in the posterior corneal surface (greater effect could be expected for steeper corneas). This effect needs to be verifi ed, but may limit the ability of CXL treatment in the earlier stages. In the long-term, a normalization of the hydration of the cornea and the fl attening effect induced by the corneal healing will result in better visual and refractive results or even in changes in the hyperopic direction when refractive index no longer plays a role and corneal fl attening induces a reduction in the myopic power of the eye typical in patients with keratoconus. The same calculations for a reduction in CCT of 50 µm are in agreement with our results (reduction of approximately 10% to 15% in CCT resulting in a shift in refractive index from 1.376 to 1.39 typical of Alphafi lcon A material with 66% equilibrium water content), impacting the overall power of the cornea from 2.00 to 3.00 D in the myopic direction, which also agrees with results commonly found after CXL. The refractive indices of hydrogel materials were considered from previously published results. 21, 22 Furthermore, changes in the refractive index of the cornea may induce errors in keratometric and keratoscopic devices, but this is less likely considering that the detection of the anterior corneal surface (tear fi lm and epithelium) will not be affected by stromal hydration changes and healing processes subsequent to CXL treatment.
One limitation of the current study is that we do not know the actual value of the corneal thickness because only measurements with Pentacam were obtained. Due to the increased densitometry, the image quality of the optical sections obtained with the Pentacam may create artifacts affecting the ability of the image analysis system to detect the edges of the cornea, thus reporting abnormal thickness values. However, the time period of changes in thickness and keratoconus does not justify this behavior because even after the cornea has Corneal Transparency After CXL for Keratoconus/Gutiérrez et al recovered transparency, CCT did not recover to normal values. This is consistent with a previous report on transient thinning of the cornea with ultrasound pachymetry after CXL treatment. 5 The slight reduction in lens densitometry seems to be related to the increasing absorption and diffusion of light by the cornea. In fact, there is not a cause for the transient increase in lens densitometry so this fi nding seems to be the result of an artifact due to increasing light absorption by the corneal tissue after CXL. Nevertheless, changes in lens densitometry were not statistically signifi cant during follow-up.
The present study demonstrates the impact of CXL in two fundamental properties of the corneal histology-CCT, which refl ects the compactness of the cornea after treatment, recovering to baseline values after 12 months, and transparency, which may refl ect changes in the histological distribution of stromal lamellae that recovers 3 months after treatment. These changes in corneal compactness may be associated with the myopic transient effect found in patients after CXL. The automatic measure using Pentacam is able to detect subtle degrees of opalescence even in mild cases of haze as graded clinically through slit-lamp examination. Further improvements in the densitometry function, possibly measuring the entire area of increased density and integrating all density measures across the corneal volume, will make this objective measure more representative of the relevant clinical features. 
